All respondents had sexual intercourse while under the influence of pregabalin and reported subjectively positive effects on their sexual activities. Since the issue of psychoactive substance use in Ukraine is stigmatised, it is difficult to access the target group. Therefore, the sample was formed using the “snowball” method, where the initial respondents were asked to provide recommendations and contacts of other persons who met the criteria for inclusion in the study. The issue of chemsex has also not gone unnoticed by countries around the world.
Tennis Shock Bumper/Vibrator Market Size: Strategic Insights & Growth Forecast 2026-2033
- The rise of gabapentinoid consumption may represent another medication misuse crisis41.
- Because the analysis was restricted to a single jurisdiction and comparisons were made within drug classes, standardized units provide a reliable measure of drug use.
- Duplicate studies were excluded to avoid data duplication and ensure the integrity of the analysis.
- While some economic evaluations of clinical trial data in NeP have been published comparing diverse medical interventions in subjects with peripheral NeP, we could not find any studies investigating real world practice conditions in NeP, including those studying PGB 43.
- Interestingly, the mean utilization of all-type medical visits was significantly reduced in all study groups, although this reduction was again more marked in the PGB-treated groups compared with the non-PGB group.
The experience of the “tramadol epidemic” in Ukraine has shown that the introduction of additional regulatory restrictions can lead to a shift to more dangerous patterns of psychoactive substance use. Researchers note that restrictions on the circulation of tramadol led to an increase in the prevalence of injecting synthetic opioids in Ukraine as a substitute for tramadol 213. At the end of 2024, the Minister of Health of Ukraine reported on the alarming situation with nalbuphine abuse, with 3 million packages sold in 2024 and only 6,000 prescriptions issued 214, and the drug itself ranked fourth in sales in Ukraine in 2024 215.
Empowering Future Growth with Bold Data Insights & Visionary Analytics
Analysts predict that sales of pregabalin will continue to lyrica no prescription grow steadily 47, 48. In Ukraine, as of March 2025, pregabalin-containing drugs were included in the list of the most commonly used medicines 49. The most common side effects of LYRICA in children are weight gain, increase in appetite, and sleepiness. If you have diabetes, you should pay attention to your skin while taking LYRICA and tell your healthcare provider about any sores or skin problems. Tell your healthcare provider about any side effect that bothers you or that does not go away. There was a high level of certainty for the responder rate on the HAM-A and CGI-I scales as well as for the discontinuation rate.
However, our study also suggests that regulating a single drug susceptible to abuse, rather than the entire class, is insufficient to address the problem. To effectively address the substitution effect—where individuals switch from one controlled medication to another within the same class when restrictions are imposed—policy changes can focus on regulating entire drug classes with abuse potential, rather than individual drugs. A gradual implementation of restrictions on a drug class may be a valuable strategy for minimizing disruption allowing patients to work with their prescribers on a gradual transition to treatment alternatives preventing access disruption. Comparing our findings with those from other countries reveals both similarities and variations in the outcomes of pregabalin policy interventions. For instance, a study in Saudi Arabia evaluating the 2018 classification of pregabalin as a controlled substance reported a 21.5% reduction in the total number of pregabalin users but a 15.5% increase in the total number of pregabalin prescriptions.
After that, drugs containing it were withdrawn from circulation in a number of countries, and it began to be sold as a “designer drug” in the form of a dietary supplement, mainly at petrol stations, for which it was slangily named “gas station heroin” by the FDA 222. All respondents reported intentions and attempts to stop recreational use of pregabalin; three of them continue to use it regularly, while the others use it occasionally. Long-term use of pregabalin increases cardiovascular risk, particularly the risk of deep vein thrombosis, peripheral vascular disease, pulmonary embolism 22, acute heart failure, and decompensation of chronic heart failure 150, 151, 152, atrioventricular block 153, 154. In rats, it has been proven that pregabalin leads to pronounced oedema and vacuolar changes in cardiomyocytes 155.